Aptus Capital Advisors, LLC Jazz Pharmaceuticals PLC Transaction History

Aptus Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$117.65 - $153.73 $1.11 Million - $1.45 Million	-9,409 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$125.18 - $143.24 $283,657 - $324,581	-2,266 Reduced 19.41%	9,409 $1.21 Million
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $162,587 - $187,101	-1,295 Reduced 9.98%	11,675 $1.66 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $288,446 - $338,505	2,368 Added 22.34%	12,970 $1.85 Million
Q4 2018 Feb 12, 2019	BUY	$115.94 - $166.74 $1.23 Million - $1.77 Million	10,602 New	10,602 $1.31 Million

514

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Aptus Capital Advisors, LLC with notifications on news.